"The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP). The device, which includes a small video camera, transmitter "...
- Patient Information:
Details with Side Effects
ZIRGAN (ganciclovir) Ophthalmic Gel 0.15% is indicated for the treatment of acute herpetic keratitis (dendritic ulcers).
DOSAGE AND ADMINISTRATION
The recommended dosing regimen for ZIRGAN (ganciclovir ophthalmic gel) is 1 drop in the affected eye 5 times per day (approximately every 3 hours while awake) until the corneal ulcer heals, and then 1 drop 3 times per day for 7 days.
Dosage Forms And Strengths
ZIRGAN contains 0.15% of ganciclovir in a sterile preserved topical ophthalmic gel.
ZIRGAN (ganciclovir ophthalmic gel) is supplied as 5 grams of a sterile, preserved, clear, colorless, topical ophthalmic gel containing 0.15% of ganciclovir in a polycoated aluminum tube with a white polyethylene tip and cap and protective band (NDC 42826-605-50).
Store at 15°C-25°C (59°F-77°F). Do not freeze.
Manufactured for: Sirion Therapeutics, Inc., Tampa, FL 33619. Manufactured By: Alliance Medical Products, Inc., Irvine, CA 92688.
Last reviewed on RxList: 9/30/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Zirgan Information
Zirgan - User Reviews
Zirgan User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.